3-D Matrix, Ltd. (TYO:7777)

Market Cap	17.65B
Revenue (ttm)	6.66B
Net Income (ttm)	-949.00M
Shares Out	110.29M
EPS (ttm)	-10.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,715,300
Average Volume	1,923,960
Open	194.00
Previous Close	160.00
Day's Range	193.00 - 210.00
52-Week Range	97.00 - 210.00
Beta	0.02
RSI	88.99
Earnings Date	Jun 12, 2025

About 3-D Matrix

3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 106
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In 2024, 3-D Matrix's revenue was 4.59 billion, an increase of 98.27% compared to the previous year's 2.31 billion. Losses were -255.00 million, -89.57% less than in 2023.